Join
Live feed
·
INSIDERFilingvia Quantisnow
OnKure Therapeutics Inc. logo

New insider Acorn Bioventures 2, L.P. claimed ownership of 1,129,730 shares (SEC Form 3)

ByQuantisnow·Wall Street's wire, on your screen.
OKUR· OnKure Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OKUR (OnKure Therapeutics Inc.) and more on Quantisnow.